Clinical data | |
---|---|
Trade names | Celospor, Celtol, Cristacef |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intravenous, intramuscular, intramammary |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 23 to 38% |
Elimination half-life | 1.2 hours |
Excretion | Renal (72%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.030.449 |
Chemical and physical data | |
Formula | C13H13N3O6S |
Molar mass | 339.32 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in gram-positive and gram-negative bacterial infections. It is a bacteriostatic antibiotic.[1][2] Cefacetrile is marketed under the trade names Celospor, Celtol, and Cristacef,[3] and as Vetimast for the treatment of mammary infections in lactating cows.[2]